BSE Live
Oct 17, 16:01Prev. Close
82.30
Open Price
81.37
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Oct 17, 15:57Prev. Close
83.53
Open Price
83.53
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
Balance Sheet of Valiant Laboratories (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
EQUITIES AND LIABILITIES | ||||||
SHAREHOLDER'S FUNDS | ||||||
Equity Share Capital | 43.45 | 43.45 | 32.56 | 16.28 | 10.50 | |
Total Share Capital | 43.45 | 43.45 | 32.56 | 16.28 | 10.50 | |
Reserves and Surplus | 190.93 | 193.43 | 67.93 | 55.18 | 78.08 | |
Total Reserves and Surplus | 190.93 | 193.43 | 67.93 | 55.18 | 78.08 | |
Total Shareholders Funds | 234.38 | 236.88 | 100.49 | 71.46 | 88.58 | |
NON-CURRENT LIABILITIES | ||||||
Long Term Borrowings | 59.40 | 59.40 | 59.40 | 59.40 | 0.27 | |
Deferred Tax Liabilities [Net] | 1.25 | 0.61 | 0.67 | 0.30 | 0.55 | |
Other Long Term Liabilities | 1.21 | 1.39 | 1.60 | 1.23 | 1.02 | |
Long Term Provisions | 0.09 | 0.08 | 0.08 | 0.00 | 0.00 | |
Total Non-Current Liabilities | 61.95 | 61.48 | 61.75 | 60.92 | 1.84 | |
CURRENT LIABILITIES | ||||||
Short Term Borrowings | 0.00 | 0.00 | 0.00 | 1.28 | 0.08 | |
Trade Payables | 19.40 | 24.76 | 47.30 | 46.44 | 12.29 | |
Other Current Liabilities | 1.41 | 1.48 | 3.11 | 1.55 | 3.39 | |
Short Term Provisions | 0.14 | 0.12 | 0.12 | 0.16 | 0.13 | |
Total Current Liabilities | 20.95 | 26.36 | 50.52 | 49.43 | 15.89 | |
Total Capital And Liabilities | 317.28 | 324.73 | 212.76 | 181.81 | 106.31 | |
ASSETS | ||||||
NON-CURRENT ASSETS | ||||||
Tangible Assets | 29.94 | 31.61 | 29.97 | 22.23 | 19.79 | |
Intangible Assets | 0.07 | 0.00 | 0.00 | 0.00 | 0.00 | |
Capital Work-In-Progress | 0.17 | 0.22 | 0.05 | 1.45 | 0.00 | |
Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Fixed Assets | 30.18 | 31.83 | 30.02 | 23.67 | 19.79 | |
Non-Current Investments | 165.06 | 80.97 | 0.01 | 0.00 | 0.00 | |
Deferred Tax Assets [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Long Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Other Non-Current Assets | 2.82 | 2.66 | 0.77 | 1.34 | 0.64 | |
Total Non-Current Assets | 198.06 | 115.46 | 30.80 | 25.02 | 20.42 | |
CURRENT ASSETS | ||||||
Current Investments | 0.00 | 37.61 | 34.02 | 0.40 | 0.00 | |
Inventories | 3.96 | 10.02 | 13.04 | 15.80 | 6.07 | |
Trade Receivables | 72.10 | 45.72 | 88.57 | 110.77 | 42.51 | |
Cash And Cash Equivalents | 27.34 | 96.72 | 0.46 | 20.13 | 18.94 | |
Short Term Loans And Advances | 0.06 | 0.03 | 32.40 | 0.00 | 0.02 | |
OtherCurrentAssets | 15.77 | 19.17 | 13.48 | 9.69 | 18.35 | |
Total Current Assets | 119.22 | 209.27 | 181.96 | 156.80 | 85.89 | |
Total Assets | 317.28 | 324.73 | 212.76 | 181.81 | 106.31 | |
OTHER ADDITIONAL INFORMATION | ||||||
CONTINGENT LIABILITIES, COMMITMENTS | ||||||
Contingent Liabilities | 76.07 | 16.73 | 0.42 | 0.87 | 0.00 | |
CIF VALUE OF IMPORTS | ||||||
Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Capital Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
EXPENDITURE IN FOREIGN EXCHANGE | ||||||
Expenditure In Foreign Currency | 38.01 | 0.17 | 0.00 | 0.00 | 0.00 | |
REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
EARNINGS IN FOREIGN EXCHANGE | ||||||
FOB Value Of Goods | -- | -- | -- | -- | -- | |
Other Earnings | 0.64 | -- | -- | -- | -- | |
BONUS DETAILS | ||||||
Bonus Equity Share Capital | 16.28 | 16.28 | 16.28 | 1.48 | -- | |
NON-CURRENT INVESTMENTS | ||||||
Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
Non-Current Investments Unquoted Book Value | -- | -- | 0.01 | -- | -- | |
CURRENT INVESTMENTS | ||||||
Current Investments Quoted Market Value | -- | 37.61 | 34.02 | 0.40 | -- | |
Current Investments Unquoted Book Value | -- | -- | -- | -- | -- |
22.08.2025
Valiant Lab Standalone June 2025 Net Sales at Rs 51.01 crore, up 170.11% Y-o-Y
22.05.2025
Valiant Lab Consolidated March 2025 Net Sales at Rs 57.79 crore, up 88.92% Y-o-Y
21.05.2025
Valiant Lab Standalone March 2025 Net Sales at Rs 57.77 crore, up 88.9% Y-o-Y
20.02.2025
Valiant Lab Consolidated December 2024 Net Sales at Rs 35.23 crore, down 13.04% Y-o-Y
22.08.2025
Valiant Lab Standalone June 2025 Net Sales at Rs 51.01 crore, up 170.11% Y-o-Y
22.05.2025
Valiant Lab Consolidated March 2025 Net Sales at Rs 57.79 crore, up 88.92% Y-o-Y
21.05.2025
Valiant Lab Standalone March 2025 Net Sales at Rs 57.77 crore, up 88.9% Y-o-Y
20.02.2025
Valiant Lab Consolidated December 2024 Net Sales at Rs 35.23 crore, down 13.04% Y-o-Y